Epigenetic Modifications as Therapeutic Targets

Curr Drug Targets. 2020;21(11):1046. doi: 10.2174/138945012111200727122724.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Drug Approval
  • Epigenesis, Genetic / drug effects*
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / genetics*

Substances

  • Antineoplastic Agents